Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03980093 · ClinicalTrials.gov registry record · NA
The REACH Study: A Novel Values-Based Intervention to Increase Endocrine Therapy Adherence Among Breast Cancer Survivors
A NA study, sponsored by University of Colorado, Boulder.
- Completed
- Registry status
- NA
- Development phase
- 88
- Enrollment target
NCT03980093 is a NA study that has completed, run by University of Colorado, Boulder. The registered enrollment target is 88 participants.
The verdict
NCT03980093, a NA study, has completed, sponsored by University of Colorado, Boulder.
- COMPLETED
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
Study Summary
This pilot trial compares two online interventions to improve adherence to anti-hormonal medication among women with the most common form of breast cancer (estrogen receptor-positive).
Interventions
- BEHAVIORAL Education
- BEHAVIORAL Values
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2019-04-01 |
| Est. Completion | 2020-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03980093
The ClinicalTrials.gov registry entry for NCT03980093 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Boulder, which has 69 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Education is the first listed.
NCT03980093 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03980093 about?
NCT03980093 is a clinical study titled "The REACH Study: A Novel Values-Based Intervention to Increase Endocrine Therapy Adherence Among Breast Cancer Survivors". This pilot trial compares two online interventions to improve adherence to anti-hormonal medication among women with the most common form of breast cancer (estrogen receptor-positive).
What is the current status of trial NCT03980093?
This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2019-04-01. Estimated completion is 2020-08-31.
What interventions are being tested in trial NCT03980093?
The interventions under investigation include: Education (BEHAVIORAL), Values (BEHAVIORAL).
Who is sponsoring clinical trial NCT03980093?
This trial is sponsored by University of Colorado, Boulder, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.